Author Kleiter, Ingo

1 to 13 of 13 Items
  • 2008 Conference Abstract
    ​ ​The TGF-beta inhibitor Smad7 controls t cell differentiation and susceptibility to autoimmune encephalomyelitis​
    Kleiter, I.; Song, J.; Croxford, A.; Lukas, D.; Fantini, M. C.; Pedre, X. & Hasan, M. et al.​ (2008)
    MULTIPLE SCLEROSIS14 ​13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis​, Montreal, CANADA.
    London​: Sage Publications Ltd.
    Details  WoS 
  • 2012 Journal Article | 
    ​ ​Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients​
    Jarius, S.; Ruprecht, K.; Wildemann, B.; Kuempfel, T.; Ringelstein, M.; Geis, C. & Kleiter, I. et al.​ (2012) 
    Journal of Neuroinflammation9 art. 14​.​ DOI: https://doi.org/10.1186/1742-2094-9-14 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Review | 
    ​ ​Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography​
    Bennett, J. L.; de Seze, J.; Lana-Peixoto, M. A.; Palace, J.; Waldman, A.; Schippling, S.& Tenembaum, S. N. et al.​ (2015)
    Multiple Sclerosis Journal, 21​(6) pp. 678​-688​.​
    Sage Publications Ltd. DOI: https://doi.org/10.1177/1352458514567216 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Conference Abstract
    ​ ​Efficacy of immunotherapies and predictors of therapy response in neuromyelitis optica spectrum disorders: analysis of 397 treatment years from 150 patients​
    Stellmann, J.-P.; Krumbholz, M.; Friede, T.; Trebst, C. & Kleiter, I.​ (2016)
    Multiple Sclerosis Journal22 ​32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)​, London, ENGLAND.
    London​: Sage Publications Ltd.
    Details  WoS 
  • 2017 Journal Article
    ​ ​Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response​
    Stellmann, J.-P.; Krumbholz, M.; Friede, T. ; Gahlen, A.; Borisow, N.; Fischer, K. & Hellwig, K. et al.​ (2017) 
    Journal of Neurology, Neurosurgery & Psychiatry88(8) pp. 639​-647​.​ DOI: https://doi.org/10.1136/jnnp-2017-315603 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions​
    Grüter, T.; Metz, I.; Gahlen, A.; Kneiphof, J.; Stork, L.; Brück, W. & Gold, R. et al.​ (2018) 
    Clinical and Experimental Neuroimmunology9(3) pp. 169​-172​.​ DOI: https://doi.org/10.1111/cen3.12466 
    Details  DOI 
  • 2020 Journal Article
    ​ ​The transitional phase of multiple sclerosis: Characterization and conceptual framework​
    Kleiter, I.; Ayzenberg, I.; Havla, J.; Lukas, C.; Penner, I.-K.; Stadelmann, C.   & Linker, R. A ​ (2020) 
    Multiple Sclerosis and Related Disorders44 pp. 102242​.​ DOI: https://doi.org/10.1016/j.msard.2020.102242 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders​
    Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al.​ (2020) 
    Neurology94(4) pp. e407​-e418​.​ DOI: https://doi.org/10.1212/WNL.0000000000008684 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients​
    Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al.​ (2020) 
    Journal of Neuroinflammation17(1).​ DOI: https://doi.org/10.1186/s12974-020-01824-2 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study​
    Abdelhak, A.; Huss, A.; Stahmann, A.; Senel, M.; Krumbholz, M.; Kowarik, M. C. & Havla, J. et al.​ (2020) 
    Contemporary Clinical Trials Communications18 pp. 100574​.​ DOI: https://doi.org/10.1016/j.conctc.2020.100574 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder​
    Ayzenberg, I.; Richter, D.; Henke, E.; Asseyer, S.; Paul, F.; Trebst, C. & Hümmert, M. W. et al.​ (2021) 
    Neurology: Neuroimmunology & Neuroinflammation8(3) pp. e985​.​ DOI: https://doi.org/10.1212/NXI.0000000000000985 
    Details  DOI 
  • 2023 Journal Article
    ​ ​Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis​
    Abdelhak, A.; Antweiler, K.; Kowarik, M. C.; Senel, M.; Havla, J.; Zettl, U. K. & Kleiter, I. et al.​ (2023) 
    Annals of Clinical and Translational Neurology, art. acn3.51969​.​ DOI: https://doi.org/10.1002/acn3.51969 
    Details  DOI 
  • 2024 Journal Article
    ​ ​Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis​
    Abdelhak, A.; Antweiler, K.; Kowarik, M. C.; Senel, M.; Havla, J.; Zettl, U. K. & Kleiter, I. et al.​ (2024) 
    Multiple Sclerosis and Related Disorders81 art. 105139​.​ DOI: https://doi.org/10.1016/j.msard.2023.105139 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page